Fiona Marshall is the founder of Sosei Group. Sosei Group has raised $21M in total funding. Latest round: Series B.
Fiona Marshall is a co-founder of Heptares Therapeutics, a clinical-stage biotechnology company based in Welwyn Garden City, UK. The company specializes in developing novel medicines by targeting G protein-coupled receptors (GPCRs) using its proprietary StaR® technology for structure-based drug design. Heptares Therapeutics was acquired by Sosei Group in 2015 for up to $400 million and has secured partnerships with pharmaceutical giants like Pfizer and Allergan.
Full founder directory · Investor directory · Company funding database · Fundraising library